OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
Sigbjørn Berentsen, Geir E. Tjønnfjord
Blood Reviews (2012) Vol. 26, Iss. 3, pp. 107-115
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, et al.
Blood (2014) Vol. 124, Iss. 19, pp. 2930-2936
Open Access | Times Cited: 309

Cold agglutinin disease
Paul Swiecicki, Livia Hegerova, Morie A. Gertz
Blood (2013) Vol. 122, Iss. 7, pp. 1114-1121
Open Access | Times Cited: 289

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
Wilma Barcellini, Bruno Fattizzo
Disease Markers (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 255

Treatment of autoimmune hemolytic anemias
Alberto Zanella, Wilma Barcellini
Haematologica (2014) Vol. 99, Iss. 10, pp. 1547-1554
Open Access | Times Cited: 243

The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill, R. Stamps, Edwin Massey, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 3, pp. 395-411
Open Access | Times Cited: 215

Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
Ulla Randen, Gunhild Trøen, Anne Tierens, et al.
Haematologica (2013) Vol. 99, Iss. 3, pp. 497-504
Open Access | Times Cited: 162

New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Wilma Barcellini
Transfusion Medicine and Hemotherapy (2015) Vol. 42, Iss. 5, pp. 287-293
Open Access | Times Cited: 153

TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins
Ju Shi, Eileen L. Rose, Andrew Singh, et al.
Blood (2014) Vol. 123, Iss. 26, pp. 4015-4022
Open Access | Times Cited: 141

Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
Sigbjørn Berentsen, Ulla Randen, Markku Oksman, et al.
Blood (2017) Vol. 130, Iss. 4, pp. 537-541
Open Access | Times Cited: 113

Cold agglutinin disease
Sigbjørn Berentsen
Hematology (2016) Vol. 2016, Iss. 1, pp. 226-231
Open Access | Times Cited: 101

How I manage patients with cold agglutinin disease
Sigbjørn Berentsen
British Journal of Haematology (2018) Vol. 181, Iss. 3, pp. 320-330
Open Access | Times Cited: 98

Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
Quentin A. Hill, Anita Hill, Sigbjørn Berentsen
Blood Advances (2019) Vol. 3, Iss. 12, pp. 1897-1906
Open Access | Times Cited: 98

Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen, Ulla Randen, Geir E. Tjønnfjord
Hematology/Oncology Clinics of North America (2015) Vol. 29, Iss. 3, pp. 455-471
Closed Access | Times Cited: 97

How I treat cold agglutinin disease
Sigbjørn Berentsen
Blood (2021) Vol. 137, Iss. 10, pp. 1295-1303
Open Access | Times Cited: 93

Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
Sigbjørn Berentsen, Tatjana Sundic
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 92

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25

Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management
Melika Loriamini, Christine Cserti‐Gazdewich, Donald R. Branch
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4296-4296
Open Access | Times Cited: 10

Autoimmune Hemolytic Anemias
J. V. Dacie, Sheila Worlledge
Elsevier eBooks (2018), pp. 50-55
Closed Access | Times Cited: 80

Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease
Sigbjørn Berentsen
Seminars in Hematology (2018) Vol. 55, Iss. 3, pp. 141-149
Closed Access | Times Cited: 60

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
Marit Jalink, Sigbjørn Berentsen, Jorge J. Castillo, et al.
Blood (2021) Vol. 138, Iss. 20, pp. 2002-2005
Open Access | Times Cited: 42

Page 1 - Next Page

Scroll to top